Acubiosys Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 18-12-2024
- Paid Up Capital ₹ 5.95 M
as on 18-12-2024
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
as on 18-12-2024
- Revenue -5.82%
(FY 2023)
- Profit 8.98%
(FY 2023)
- Ebitda 6.81%
(FY 2023)
- Net Worth 33.22%
(FY 2023)
- Total Assets 20.52%
(FY 2023)
About Acubiosys
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 5.95 M.
The company currently has active open charges totaling ₹4.00 M.
Srinivasa Maddi and Raja Velpuri serve as directors at the Company.
- CIN/LLPIN
U73100TG2017PTC115047
- Company No.
115047
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 2017
- Date of AGM
23 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Acubiosys Private Limited offer?
Acubiosys Private Limited offers a wide range of products and services, including Child and Baby Care Products, Baby Care Products, Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant, Hand Wash, Industrial Chemicals & Supplies, Biocides.
Who are the key members and board of directors at Acubiosys?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasa Maddi  | Director | 08-Feb-2017 | Current |
| Raja Velpuri | Director | 08-Feb-2017 | Current |
Financial Performance of Acubiosys.
Acubiosys Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.82% decrease. The company also saw a slight improvement in profitability, with a 8.98% increase in profit. The company's net worth Soared by an impressive increase of 33.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Acubiosys?
Unlock access to Acubiosys's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Aug 2020 | ₹4.00 M | Open |
How Many Employees Work at Acubiosys?
Unlock and access historical data on people associated with Acubiosys, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acubiosys, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acubiosys's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
